Now showing items 1-1 of 1
Using biomedical data to identify genetic variants that drive drug responses in Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML) is a heterogeneous cancer of the blood that progresses quickly, with approximately 10,000 AML related deaths reported annually in the United States. Patients with AML tend to have genetic variations, which can significantly affect drug sensitivity and treatment outcomes. While massive amounts ...